Supplies of crucial obstetric medicines are running short in Australia, putting the health of pregnant women at risk and highlighting systemic problems relating to access to treatment, according to a new report.

The review, published in the Medical Journal of Australia on Monday, called on the government to create a publicly funded entity dedicated to registering, importing and manufacturing critical medications for use during pregnancy.